Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] funded will help us get more and better treatments to our community by June Kinoshita, FSHD Society Many of you have heard us describe the FSHD Society as a “research-focused […]
Losmapimod has the potential to be the first drug to treat FSHD The much-anticipated Phase 3 clinical trial of losmapimod has formally begun with the dosing of the first volunteer, […]
[…] Engagement “Positive benefit/risk supports losmapimod’s potential to be a transformative therapy for the treatment of FSHD”-Fulcrum Therapeutics Fulcrum Therapeutics announced today that losmapimod, its experimental therapy for facioscapulohumeral muscular dystrophy, […]
[…] testing the effect of a drug called losmapimod in individuals with facioscapulohumeral muscular dystrophy ( FSHD). The drug, which is taken as a pill twice a day, is intended to […]
[…] but they are severely hypomethylated. (Figure courtesy of Peter Jones, PhD.) Yes, we’re talking about FSHD On those rare occasions (such as the FSHD Connect meeting) when large numbers of […]
